BRYAN SCHINAMAN: Open Payments
NPI 1902261431 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 46 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $818 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $440 |
| ABBVIE INC. | 16 | $297 |
| Lilly USA, LLC | 9 | $221 |
| Novo Nordisk Inc | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Exact Sciences Corporation | 1 | $27 |
| Insulet Corporation | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
| Dexcom, Inc. | 1 | $14 |
Products named: VRAYLAR, FARXIGA, AIRSUPRA, JARDIANCE, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
